Your browser doesn't support javascript.
loading
Vaccination is Australia's most important COVID-19 public health action, even though herd immunity is unlikely
Emma S McBryde; Michael T Meehan; Jamie Sziklay; Adeshina Adekunle; Abdul Kuddus; Samson Ogunlade; Pavithra Jayasundara; Romain Ragonnet; James M Trauer; Robert C Cope.
Afiliação
  • Emma S McBryde; James Cook University
  • Michael T Meehan; James Cook University
  • Jamie Sziklay; University of Hawaii
  • Adeshina Adekunle; Department of Defence
  • Abdul Kuddus; James Cook University
  • Samson Ogunlade; James Cook University
  • Pavithra Jayasundara; University of Monash
  • Romain Ragonnet; Monash University
  • James M Trauer; Monash University
  • Robert C Cope; Australian National University
Preprint em Inglês | medRxiv | ID: ppmedrxiv-21260642
ABSTRACT
The Australian National Cabinet four-step plan to transition to post-pandemic re-opening begins with vaccination to achieve herd protection and protection of the health system against a surge in COVID-19 cases. Assuming a pre-vaccination reproduction number for the Delta variant of 5, we show that for the current Mixed program of vaccinating over 60s with AstraZeneca and 16-60s with Pfizer we would not achieve herd immunity. We would need to cover 85% of the population (including many 5-16 year-olds to achieve herd immunity). At lower reproduction number of 3 and our current Mixed strategy, we can achieve herd immunity without vaccinating 5-15 year olds. This will be achieved at a 60% coverage pursuing a strategy targetting high transmitters or 70% coverage using a strategy targetting the vulnerable first. A reproduction number of 7 precludes achieving herd immunity, however vaccination is able to prevent 75% of deaths compared with no vaccination. We also examine the impact of vaccination on death in the event that herd immunity is not achieved. Direct effects of vaccination on reducing death are very good for both Pfizer and AstraZeneca vaccines. However we estimate that the Mixed or Pfizer program performs better than the AstraZeneca program. Furthermore, vaccination levels below the herd immunity threshold can lead to substantial (albeit incomplete) indirect protection for both vaccinated and unvaccinated populations. Given the potential for not reaching herd immunity, we need to consider what level of severe disease and death is acceptable, balanced against the consequences of ongoing aggressive control strategies. O_TEXTBOXThe known SARS CoV-2 variants are known to be more transmissible than the original Wuhan strain, making herd immunity challenging. The new We find that vaccinating the older-vulnerable age groups first leads to fewer deaths and is the optimal strategy vaccine coverage is under 70%. Herd immunity achieved solely through vaccinating adults is unlikely, but can still be expected to prevent substantial numbers of deaths. The implications Australia is unlikely to achieve herd immunity unless vaccination is combined with substantial public health measures. Even without herd immunity, vaccination remains a highly effective means to mitigate the impact of COVID-19. C_TEXTBOX
Licença
cc_by_nc_nd
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Rct Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Rct Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
...